ORGANOGENESIS HOLDINGS INC.

ORGO · NASDAQ

Research and Development in Biotechnology

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

ESG Scores

Overall ESG

2.1

Environmental

4.6

Social

2.5

Governance

5.7

Gender Diversity

Female Directors0.0909%

Female Executives0.06134969325153374%

CEO GenderMale

Market Data

Price$2.63+0.01 (+0.38%)

Market Cap$338M

P/E Ratio124.23

EPS$—

52W High$7.08

52W Low$2.04

Beta1.33